Nu Skin Enterprises announced that its preliminary revenue for the fourth quarter of 2024 reached the high end of the company’s guidance range. This update was provided ahead of its presentation at the ICR Conference.
The company's President and CEO, Ryan Napierski, and CFO, James Thomas, were scheduled to discuss company strategy and business performance, including the recent strategic transaction of Mavely for $250 million.
The full financial results for the fourth quarter and full year 2024 are scheduled to be released after the market closes on Thursday, February 13, 2025.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.